Personal information

No personal information available

Activities

Employment (1)

Brigham and Women's Hospital: Boston, MA, US

2012-10-01 to present | Research Specialist (Neurosurgery)
Employment
Source: Self-asserted source
Michal Nowicki

Education and qualifications (2)

Medical University of Warsaw: Warsaw, PL

Ph.D. Medical Biology
Qualification
Source: Self-asserted source
Michal Nowicki

Uniwersytet Jagielloński w Krakowie: Krakow, Małopolska, PL

1995-01-06 to 2000-01-06 | M.Sc. Biotechnology
Qualification
Source: Self-asserted source
Michal Nowicki

Funding (1)

Innovative approaches for the advancement of glioblastoma therapies

2019-09-17 to 2024-08-31 | Grant
National Cancer Institute (Rockville, US)
GRANT_NUMBER: R50CA243706
Source: Self-asserted source
Michal Nowicki via DimensionsWizard

Works (40)

Drug Resistance in Glioma Cells Induced by a Mesenchymal–Amoeboid Migratory Switch

Biomedicines
2021-12-22 | Journal article
Contributors: Sophie E. Ketchen; Filomena O. Gamboa-Esteves; Sean E. Lawler; Michal O. Nowicki; Arndt Rohwedder; Sabine Knipp; Sally Prior; Susan C. Short; John E. Ladbury; Anke Brüning-Richardson
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Magnetic Resonance Elastography reveals effects of anti-angiogenic glioblastoma treatment on tumor stiffness and captures progression in an orthotopic mouse model.

Cancer Imaging
2020-05-12 | Journal article
Source: Self-asserted source
Michal Nowicki

Immune Escape Mediated by Exosomal PD-L1 in Cancer.

Advanced biosystems
2020-05-07 | Journal article
Source: Self-asserted source
Michal Nowicki

Proteomic Analysis Implicates Vimentin in Glioblastoma Cell Migration

Cancers
2019-04 | Journal article | Author
Contributors: Michal Nowicki; Josie L. Hayes; E. Antonio Chiocca; Sean E. Lawler
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data.

Analytical chemistry
2019-04-22 | Journal article
Source: Self-asserted source
Michal Nowicki

MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy

Non-Coding RNA
2019-03 | Journal article | Author
Contributors: Daisuke Ogawa; Khairul Ansari; Michal Nowicki; Elzbieta Salinska; Agnieszka Bronisz; Jakub Godlewski
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis.

The Journal of clinical investigation
2019-03-11 | Journal article
Source: Self-asserted source
Michal Nowicki

The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.

Nature communications
2019-01-25 | Journal article
Source: Self-asserted source
Michal Nowicki

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma.

Neuro-oncology
2018-01-01 | Journal article
Source: Self-asserted source
Michal Nowicki

Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models.

Cancer letters
2017-12-13 | Journal article
Source: Self-asserted source
Michal Nowicki

Characterization of glioblastoma in an orthotopic mouse model with magnetic resonance elastography.

NMR in biomedicine
2017-11-29 | Journal article
Source: Self-asserted source
Michal Nowicki

Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors.

Scientific reports
2017-06-01 | Journal article
Source: Self-asserted source
Michal Nowicki

MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer.

Stem cell reports
2017-05-18 | Journal article
Source: Self-asserted source
Michal Nowicki

BKM-120 (Buparlisib): A Phosphatidyl-Inositol-3 Kinase Inhibitor with Anti-Invasive Properties in Glioblastoma.

Scientific reports
2016-02-05 | Journal article
Source: Self-asserted source
Michal Nowicki

In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.

Gene therapy
2015-07-21 | Journal article
Source: Self-asserted source
Michal Nowicki

Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.

Cancer research
2013-12-05 | Journal article
Source: Self-asserted source
Michal Nowicki

MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.

Neuro-oncology
2013-06-03 | Journal article
Source: Self-asserted source
Michal Nowicki
grade
Preferred source (of 2)‎

Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations.

Cancer research
2013-06-01 | Journal article
Source: Self-asserted source
Michal Nowicki

Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain.

Gene therapy
2012-12-13 | Journal article
Source: Self-asserted source
Michal Nowicki

The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.

Journal of virology
2012-02-08 | Journal article
Source: Self-asserted source
Michal Nowicki

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.

Nature cell biology
2011-12-18 | Journal article
Source: Self-asserted source
Michal Nowicki

Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling.

Neoplasia (New York, N.Y.)
2011-09-01 | Journal article
Source: Self-asserted source
Michal Nowicki

Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments.

Cancer research
2011-06-22 | Journal article
Source: Self-asserted source
Michal Nowicki

BCR/ABL stimulates WRN to promote survival and genomic instability.

Cancer research
2010-12-01 | Journal article
Source: Self-asserted source
Michal Nowicki

The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells.

Journal of neuro-oncology
2010-10-12 | Journal article
Source: Self-asserted source
Michal Nowicki

microRNA-451: A conditional switch controlling glioma cell proliferation and migration.

Cell cycle (Georgetown, Tex.)
2010-07-30 | Journal article
Source: Self-asserted source
Michal Nowicki

MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

Molecular cell
2010-03-01 | Journal article
Source: Self-asserted source
Michal Nowicki

Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy.

Tissue engineering. Part C, Methods
2009-12-01 | Journal article
Source: Self-asserted source
Michal Nowicki

A mathematical model for pattern formation of glioma cells outside the tumor spheroid core.

Journal of theoretical biology
2009-07-09 | Journal article
Source: Self-asserted source
Michal Nowicki

ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression.

Molecular therapy : the journal of the American Society of Gene Therapy
2009-02-17 | Journal article
Source: Self-asserted source
Michal Nowicki

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

Cancer research
2008-11-01 | Journal article
Source: Self-asserted source
Michal Nowicki

Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3.

Neuro-oncology
2008-08-20 | Journal article
Source: Self-asserted source
Michal Nowicki

Estimating the cell density and invasive radius of three-dimensional glioblastoma tumor spheroids grown in vitro.

Applied optics
2007-08-01 | Journal article
Source: Self-asserted source
Michal Nowicki

BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance.

Blood
2006-03-09 | Journal article
Source: Self-asserted source
Michal Nowicki

BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells.

DNA repair
2005-11-16 | Journal article
Source: Self-asserted source
Michal Nowicki

BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin.

Oncogene
2005-06-01 | Journal article
Source: Self-asserted source
Michal Nowicki

BCR/ABL recruits p53 tumor suppressor protein to induce drug resistance.

Cell cycle (Georgetown, Tex.)
2004-11-10 | Journal article
Source: Self-asserted source
Michal Nowicki

BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks.

Blood
2004-08-10 | Journal article
Source: Self-asserted source
Michal Nowicki

Chronic myelogenous leukemia molecular signature.

Oncogene
2003-06-01 | Journal article
Source: Self-asserted source
Michal Nowicki

BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance.

Molecular cell
2001-10-01 | Journal article
Source: Self-asserted source
Michal Nowicki